Who Just Raised

Evia Bio, Inc.

Minneapolis, MN · Biotechnology

Evia Bio, Inc. is a biotechnology company based in Minneapolis, Minnesota. In a Form D filed with the SEC on September 28, 2026, it reported raising $5,453,532 from 19 investors as part of an offering of up to $5,453,532. The first sale in the offering took place on September 14, 2026.

Amount raised
$5,453,532
Offering size
$5,453,532
Investors so far
19
First sale
September 14, 2026
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Minneapolis, Minnesota
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $5,453,532 $5,453,532 19 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Minnesota

Company Location Sector Raised Target Filed
Surgicare of Minneapolis, Ltd. St. Louis Park, MN Health Care — $342K
Pelvital USA, Inc. Eagan, MN Health Care $520K $4M
ProEncia Biotechnology Inc. Woodbury, MN Health Care $1.5M $2M
InSitu Biologics, Inc. Oakdale, MN Health Care $1.3M $2.5M
Pelva Health Corp Edina, MN Health Care $30K $2M
Gentle Caring Mind Healthcare LLC Coon Rapids, MN Health Care $50K $200K